Hiroji Iwata Selected Research

Anthracyclines

10/2020	Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial.
12/2017	A phase I/II pharmacokinetics/pharmacodynamics study of irinotecan combined with S-1 for recurrent/metastatic breast cancer in patients with selected UGT1A1 genotypes (the JBCRG-M01 study).
3/2017	Comparison of an AC-taxane versus AC-free regimen and paclitaxel versus docetaxel in patients with lymph node-positive breast cancer: Final results of the National Surgical Adjuvant Study of Breast Cancer 02 trial, a randomized comparative phase 3 study.
1/2017	Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy.
1/2017	Efficacy and safety of low-dose capecitabine plus docetaxel versus single-agent docetaxel in patients with anthracycline-pretreated HER2-negative metastatic breast cancer: results from the randomized phase III JO21095 trial.
1/2014	A multicenter phase II study of TSU-68, an oral multiple tyrosine kinase inhibitor, in combination with docetaxel in metastatic breast cancer patients with anthracycline resistance.
8/2013	A multicenter phase II study of TSU-68, a novel oral multiple tyrosine kinase inhibitor, in patients with metastatic breast cancer progressing despite prior treatment with an anthracycline-containing regimen and taxane.
10/2010	Impact of prophylactic pyridoxine on occurrence of hand-foot syndrome in patients receiving capecitabine for advanced or metastatic breast cancer.
11/2009	Phase II study of gemcitabine monotherapy as a salvage treatment for Japanese metastatic breast cancer patients after anthracycline and taxane treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroji Iwata Research Topics

Disease

258	Breast Neoplasms (Breast Cancer) 04/2024 - 01/2002
96	Neoplasms (Cancer) 04/2024 - 01/2002
28	Neoplasm Metastasis (Metastasis) 12/2023 - 10/2002
24	Neutropenia 11/2023 - 08/2008
19	Triple Negative Breast Neoplasms 12/2023 - 12/2012
18	Disease Progression 04/2024 - 01/2007
7	Diarrhea 06/2023 - 12/2015
6	Carcinoma (Carcinomatosis) 01/2024 - 10/2002
6	Fatigue 10/2022 - 07/2015
6	Leukopenia 09/2021 - 08/2008
5	Vomiting 01/2021 - 10/2007
5	Nausea 01/2021 - 10/2007
5	Febrile Neutropenia 01/2020 - 10/2007
5	Brain Neoplasms (Brain Tumor) 11/2017 - 08/2013
4	Pathologic Complete Response 11/2023 - 04/2011
4	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2023 - 08/2020
4	Pneumonia (Pneumonitis) 01/2023 - 08/2020
4	Thrombocytopenia (Thrombopenia) 08/2022 - 01/2015
4	Anemia 01/2021 - 11/2014
4	Stomach Neoplasms (Stomach Cancer) 01/2020 - 04/2002
4	Stomatitis 12/2019 - 11/2014
4	Carcinogenesis 10/2019 - 02/2003
4	Hand-Foot Syndrome 11/2018 - 10/2010
4	Ductal Carcinoma 09/2018 - 06/2006
4	Edema (Dropsy) 03/2017 - 01/2005
3	Arthralgia (Joint Pain) 10/2023 - 01/2005
3	Peripheral Nervous System Diseases (PNS Diseases) 01/2022 - 01/2020
3	Lymphatic Metastasis 10/2021 - 11/2002
3	Noninfiltrating Intraductal Carcinoma (DCIS) 03/2021 - 08/2017
3	Alopecia (Baldness) 11/2020 - 12/2015
3	Exanthema (Rash) 01/2019 - 01/2015
3	Hyperglycemia 01/2019 - 11/2014

Drug/Important Bio-Agent (IBA)

65	Hormones (Hormone)IBA 04/2024 - 01/2002
42	Estrogen ReceptorsIBA 12/2023 - 10/2002
42	Trastuzumab (Herceptin)FDA Link 06/2023 - 10/2005
34	ErbB Receptors (EGF Receptor)IBA 01/2024 - 05/2011
24	human ERBB2 proteinIBA 12/2023 - 10/2008
22	palbociclibIBA 11/2023 - 07/2015
17	Aromatase InhibitorsIBA 03/2023 - 06/2010
17	Fulvestrant (Faslodex)FDA Link 01/2023 - 12/2013
16	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 01/2009
14	Docetaxel (Taxotere)FDA Link 08/2021 - 01/2005
14	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2020 - 02/2004
11	Cyclin-Dependent Kinase 4IBA 10/2023 - 01/2017
11	Biomarkers (Surrogate Marker)IBA 01/2023 - 07/2007
11	exemestane (Aromasin)FDA Link 01/2023 - 04/2011
10	abemaciclibIBA 04/2024 - 01/2019
10	trastuzumab deruxtecanIBA 01/2024 - 01/2019
10	taxaneIBA 01/2023 - 11/2009
10	Capecitabine (Xeloda)FDA Link 11/2018 - 02/2004
10	Tamoxifen FDA LinkGeneric 12/2014 - 07/2003
9	Ado-Trastuzumab EmtansineIBA 01/2023 - 01/2015
9	Letrozole (Femara)FDA LinkGeneric 01/2023 - 04/2011
9	Progesterone Receptors (Progesterone Receptor)IBA 10/2021 - 07/2003
9	AnthracyclinesIBA 10/2020 - 11/2009
8	130-nm albumin-bound paclitaxelIBA 11/2021 - 05/2017
8	atezolizumabIBA 11/2021 - 11/2018
8	Phenobarbital (Luminal)FDA Link 09/2021 - 04/2011
8	Anastrozole (Arimidex)FDA LinkGeneric 11/2014 - 06/2010
7	Proteins (Proteins, Gene)FDA Link 03/2023 - 02/2007
7	Lapatinib (GW572016)FDA Link 08/2021 - 08/2013
7	Fluorouracil (Carac)FDA LinkGeneric 04/2020 - 01/2005
7	Epirubicin (Ellence)FDA LinkGeneric 04/2020 - 02/2004
6	pembrolizumabIBA 12/2023 - 12/2020
6	neratinibIBA 01/2023 - 03/2016
6	Tyrosine Kinase InhibitorsIBA 01/2023 - 08/2013
6	pertuzumabIBA 09/2022 - 05/2018
5	LigandsIBA 05/2024 - 10/2020
5	Epidermal Growth Factor (EGF)IBA 04/2024 - 05/2010
5	EnzymesIBA 01/2023 - 04/2002
5	Bevacizumab (Avastin)FDA Link 06/2022 - 10/2011
5	B7-H1 AntigenIBA 01/2022 - 11/2018
5	Gemcitabine FDA Link 01/2022 - 11/2009
5	eribulin FDA Link 01/2018 - 06/2013
4	Immunoconjugates (Immunoconjugate)IBA 10/2023 - 01/2015
4	Immune Checkpoint InhibitorsIBA 01/2023 - 11/2017
4	Albumin-Bound Paclitaxel FDA Link 01/2022 - 04/2015
4	Carboplatin (JM8)FDA LinkGeneric 01/2022 - 06/2014
4	Monoclonal AntibodiesIBA 01/2020 - 10/2005
4	Everolimus FDA Link 10/2019 - 05/2013
4	ORALIT (ORS)IBA 02/2011 - 04/2002
3	Messenger RNA (mRNA)IBA 01/2023 - 06/2006
3	Alanine Transaminase (SGPT)IBA 01/2023 - 01/2017
3	TeaIBA 01/2022 - 08/2021
3	Estrogens (Estrogen)FDA Link 10/2019 - 04/2016
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 09/2014
3	Goserelin (Zoladex)FDA Link 01/2017 - 04/2012
3	thiamine triphosphorate (TTP)IBA 03/2015 - 02/2010

Therapy/Procedure

119	Therapeutics 04/2024 - 07/2003
60	Drug Therapy (Chemotherapy) 03/2024 - 01/2005
23	Neoadjuvant Therapy 11/2023 - 01/2005
18	Adjuvant Chemotherapy 06/2023 - 10/2005
15	Radiotherapy 04/2024 - 09/2007
8	Segmental Mastectomy (Lumpectomy) 04/2023 - 01/2005
7	Lymph Node Excision (Lymph Node Dissection) 07/2020 - 11/2002
6	Mastectomy (Mammectomy) 12/2023 - 09/2018
5	Mammaplasty (Breast Reconstruction) 10/2023 - 09/2018
4	Drug Tapering 08/2022 - 10/2016
3	Operative Surgical Procedures 05/2019 - 05/2017
3	Duration of Therapy 01/2019 - 01/2007